MedPath

Effect of Resin Infiltration on Hypersensitivity and Satisfaction in Children With Enamel Defects

Not Applicable
Active, not recruiting
Conditions
Molar Incisor Hypomineralization, Enamel Hypoplasia, Dental Hypersensitivity, Developmental Enamel Defects
Registration Number
NCT07118111
Lead Sponsor
Gizem Tıraşçı
Brief Summary

This study evaluates the effect of resin infiltration on dental sensitivity, quality of life, and satisfaction in children aged 7-14 with enamel defects in their front teeth. Forty children received treatment, and outcomes were measured through sensitivity tests and questionnaires for both children and parents.

Detailed Description

Developmental enamel defects can negatively impact oral health-related quality of life by causing esthetic concerns and dental hypersensitivity in children. This prospective clinical study included 40 children aged 7-14 years diagnosed with hypomineralization or hypoplasia in their anterior teeth. All participants received resin infiltration treatment. Dental hypersensitivity was evaluated pre- and post-treatment using the Schiff Cold Air Sensitivity Scale (SCASS). Oral health-related quality of life was assessed using the Pediatric Oral Health-Related Quality of Life (POQL) scale through both child and parent forms. Post-treatment esthetic satisfaction levels were recorded based on reports from both children and their parents. The study aimed to determine the impact of resin infiltration on improving sensitivity, quality of life, and satisfaction in this population.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Children aged between 7 and 14 years.
  • Children in good general health without any systemic disease.
  • Presence of at least one anterior permanent tooth with hypomineralization or hypoplasia.
  • Teeth with lesions larger than 1 mm that are suitable for resin infiltration treatment.
  • Voluntary participation of both the child and their parent/guardian in the study, with signed informed consent.
Exclusion Criteria
  • Children with systemic diseases or undergoing medical treatment.
  • Cases with active caries, trauma, restorations, or endodontic treatment applied or required on anterior teeth.
  • Individuals who have previously received resin infiltration or similar treatment on the same tooth.
  • Children with a history of allergies or sensitivity to the materials used in the procedure.
  • Individuals who have received interventions such as fluoride varnish, fissure sealants, or tooth whitening on their teeth.
  • Children who do not possess the cognitive ability to understand and respond to the questionnaire or sensitivity assessment.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Change in Dental Hypersensitivity and Patient-Parent Satisfaction1 month, 3 months, and 6 months after treatment

Dental hypersensitivity will be assessed using the Schiff Cold Air Sensitivity Scale (SCASS) before treatment and at 1, 3, and 6 months post-treatment. Patient and parent satisfaction regarding esthetic and functional outcomes will be measured through standardized questionnaires administered after treatment.

Secondary Outcome Measures
NameTimeMethod
ral Health-Related Quality of Life, Esthetic Evaluation, Treatment ComplianceBaseline, 1 month, 3 months, and 6 months after treatment

Oral health-related quality of life (OHRQoL) will be measured using the Pediatric Oral Health-Related Quality of Life (POQL) scale completed by both children and their parents before treatment and at follow-up visits. Esthetic changes will be assessed via clinical evaluations and patient/parent satisfaction surveys. Treatment compliance and acceptability will be recorded during the intervention process. Any adverse effects or complications following resin infiltration treatment will be monitored and documented throughout the study period.

Trial Locations

Locations (1)

Inonu University

🇹🇷

Malatya, Battalgazi, Turkey

Inonu University
🇹🇷Malatya, Battalgazi, Turkey

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.